Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - RETAINED EARNINGS
Retained Earnings AKBA - Akebia Therapeutics, Inc.
-1.61 B
LAST VALUE
-4.96%
2 YEAR CAGR
-25.62%
5 YEAR CAGR
-38.11%
10 YEAR CAGR